Abiopharma

SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes

Director MILANO VINCENT 🟢 acquired 676 shares of BIOCRYST PHARMACEUTICALS INC (BCRX) at $8.31 Transaction Date: Aug 29, 2025 | Filing ID: 000003

New Form 8-K - Galera Therapeutics, Inc. Filed: 2025-09-03 AccNo: 0001193125-25-194948 Size: 135 KB Item 1.01: Entry into a Material Definitive Agreement

New Form 144 - ANI PHARMACEUTICALS INC Filed: 2025-09-03 AccNo: 0001950047-25-006691 Size: 6 KB

Barnes Dawn Wilson 🟢 acquired 5.0K shares of Green Thumb Industries Inc. (GTII/GTBIF) Transaction Date: Sep 01, 2025 | Filing ID: 023510

New Form 144 - IONIS PHARMACEUTICALS INC Filed: 2025-09-03 AccNo: 0001969223-25-000715 Size: 4 KB

New Form 8-K - Mineralys Therapeutics, Inc. Filed: 2025-09-03 AccNo: 0001933414-25-000120 Size: 707 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 144 - INTUITIVE SURGICAL INC Filed: 2025-09-03 AccNo: 0001950047-25-006686 Size: 5 KB

Hologic - Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

New Form 424B5 - Mineralys Therapeutics, Inc. Filed: 2025-09-03 AccNo: 0001933414-25-000119 Size: 1 MB

Novavax Statement on Publicly Available COVID-19 Vaccine Data

Amlan International to Exhibit and Present at the XXVII Central American and Caribbean Poultry Congress in Panama City

New Form 8-K - Precipio, Inc. Filed: 2025-09-03 AccNo: 0001104659-25-086995 Size: 216 KB Item 1.02: Termination of a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits